seekingalpha.com
/1 month ago
Latest updates for Vir
Fresh curated links around VIR are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Vir Biotechnology, Inc. (VIR) Presents at EASL Congress 2026 - Slideshow
- Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally
- Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
fool.com
/1 month ago
Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally
Vir Biotechnology develops immunology-based therapies targeting infectious diseases through global partnerships and scientific innovation.
fool.com
/1 month ago
Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares
Vir Biotechnology develops antibody and RNA-based therapies for infectious diseases, leveraging partnerships and a robust clinical pipeline.
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Vir
seekingalpha.com
Recent coverage from public sources
Public source
fool.com
Recent coverage from public sources
Public source